{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:45:35Z","timestamp":1740109535243,"version":"3.37.3"},"reference-count":26,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Angiol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Eisenmenger syndrome (ES) is defined as the process in which a long-standing left-to-right cardiac shunt caused by a congenital heart defect is eventually reversed into a cyanotic right-to-left shunt. It is crucial to recognize this grave pathology at the earliest because once it develops, treatment by medical or surgical means becomes even more challenging. In past decades, various therapeutic options have been developed that address the specific pathophysiological aspects of the disease and have shown to improve functional capacity and quality of life. There are three major therapeutic pathways in pulmonary hypertension treatment - endothelin receptor antagonists, phosphodiesterase type-5 inhibitors, and prostacyclin derivatives. These therapies not only improve hemodynamic parameters and exercise capacity but they also improve prognosis with various form of Pulmonary hypertension including ES. We report a case of a 35-year-old female of ostium secundum atrial septal defect with ES, started on upfront combination therapy of ambrisentan and tadalafil who demonstrated marked improvement after 3 months of medical therapy.<\/jats:p>","DOI":"10.1055\/s-0039-1696979","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T23:00:08Z","timestamp":1569020408000},"page":"305-309","source":"Crossref","is-referenced-by-count":2,"title":["Medical Therapy for Eisenmenger Syndrome: A Case Report and Review of Literature"],"prefix":"10.1055","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2360-7580","authenticated-orcid":false,"given":"Akshyaya","family":"Pradhan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, King George's Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8097-7035","authenticated-orcid":false,"given":"Shweta","family":"Vohra","sequence":"additional","affiliation":[{"name":"Department of Cardiology, King George's Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pravesh","family":"Vishwakarma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, King George's Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi","family":"Sethi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, King George's Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2019,9,20]]},"reference":[{"issue":"23","key":"ref1","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1093\/eurheartj\/ehq249","article-title":"ESC guidelines for the management of grown-up congenital heart disease (new version 2010)","volume":"31","author":"H Baumgartner","year":"2010","journal-title":"Eur Heart J"},{"issue":"08","key":"ref2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/CIRCULATIONAHA.105.592386","article-title":"Pulmonary vascular disease in adults with congenital heart disease","volume":"115","author":"G P Diller","year":"2007","journal-title":"Circulation"},{"issue":"04","key":"ref3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/eurheartj\/ehp022","article-title":"A meta-analysis of randomized controlled trials in pulmonary arterial hypertension","volume":"30","author":"N Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"issue":"03","key":"ref4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1183\/09031936.04.00028404","article-title":"Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2","volume":"24","author":"M Humbert","year":"2004","journal-title":"Eur Respir J"},{"issue":"06","key":"ref5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1183\/09031936.04.00051104","article-title":"Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension","volume":"24","author":"M M Hoeper","year":"2004","journal-title":"Eur Respir J"},{"issue":"05","key":"ref6","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1183\/09031936.05.00075305","article-title":"Goal-oriented treatment and combination therapy for pulmonary arterial hypertension","volume":"26","author":"M M Hoeper","year":"2005","journal-title":"Eur Respir J"},{"issue":"18","key":"ref7","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2010.01.027","article-title":"Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial","volume":"55","author":"V V McLaughlin","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1164\/rccm.200603-358OC","article-title":"Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension","volume":"174","author":"V V McLaughlin","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"08","key":"ref9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.7326\/0003-4819-149-8-200810210-00004","article-title":"Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial","volume":"149","author":"G Simonneau","year":"2008","journal-title":"Ann Intern Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension","volume":"373","author":"N Galie","year":"2015","journal-title":"N Engl J Med"},{"issue":"03","key":"ref11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijcard.2010.05.066","article-title":"Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and\/or the Eisenmenger syndrome","volume":"151","author":"E L Tay","year":"2011","journal-title":"Int J Cardiol"},{"issue":"01","key":"ref12","first-page":"55","article-title":"The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension","volume":"55","author":"A Bharani","year":"2003","journal-title":"Indian Heart J"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ijcard.2006.10.017","article-title":"Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship","volume":"120","author":"N Garg","year":"2007","journal-title":"Int J Cardiol"},{"issue":"04","key":"ref14","first-page":"342","article-title":"Sildenafil for pulmonary hypertension secondary to congenital heart diseases","volume":"59","author":"A Gupta","year":"2007","journal-title":"Indian Heart J"},{"issue":"03","key":"ref15","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ijcard.2010.02.020","article-title":"Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy","volume":"149","author":"E L Tay","year":"2011","journal-title":"Int J Cardiol"},{"issue":"06","key":"ref16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/jcph.78","article-title":"Impact of sildenafil on survival of patients with Eisenmenger syndrome","volume":"53","author":"Y J Sun","year":"2013","journal-title":"J Clin Pharmacol"},{"issue":"05","key":"ref17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1747-0803.2011.00561.x","article-title":"Clinical efficacy of phosphodiesterase-5 inhibitor tadalafil in Eisenmenger syndrome--a randomized, placebo-controlled, double-blind crossover study","volume":"6","author":"S Mukhopadhyay","year":"2011","journal-title":"Congenit Heart Dis"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"N Gali\u00e8","year":"2006","journal-title":"Circulation"},{"issue":"08","key":"ref19","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/hrt.2006.089185","article-title":"Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease","volume":"93","author":"G P Diller","year":"2007","journal-title":"Heart"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.amjcard.2013.08.003","article-title":"Effects of inhaled iloprost on exercise capacity, quality of life, and cardiac function in patients with pulmonary arterial hypertension secondary to congenital heart disease (the Eisenmenger syndrome) (from the EIGER Study)","volume":"112","author":"K S Cha","year":"2013","journal-title":"Am J Cardiol"},{"issue":"26","key":"ref21","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","article-title":"Selexipag for the treatment of pulmonary arterial hypertension","volume":"373","author":"O Sitbon","year":"2015","journal-title":"N Engl J Med"},{"issue":"09","key":"ref22","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.amjcard.2010.12.051","article-title":"Ambrisentan for pulmonary arterial hypertension due to congenital heart disease","volume":"107","author":"W A Zuckerman","year":"2011","journal-title":"Am J Cardiol"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.118.033575","article-title":"Evaluation of macitentan in patients with Eisenmenger syndrome","volume":"139","author":"M A Gatzoulis","year":"2019","journal-title":"Circulation"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"e000399","DOI":"10.1136\/openhrt-2016-000399","article-title":"Effect of dual pulmonary vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease: a retrospective analysis","volume":"3","author":"O Monfredi","year":"2016","journal-title":"Open Heart"},{"issue":"09","key":"ref25","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/eurheartj\/ehq011","article-title":"Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial","volume":"31","author":"K Iversen","year":"2010","journal-title":"Eur Heart J"},{"issue":"03","key":"ref26","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijcard.2010.10.051","article-title":"Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology","volume":"155","author":"M D'Alto","year":"2012","journal-title":"Int J Cardiol"}],"container-title":["International Journal of Angiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0039-1696979.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T23:33:32Z","timestamp":1637624012000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0039-1696979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,20]]},"references-count":26,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2021,11,22]]},"published-print":{"date-parts":[[2021,12]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0039-1696979","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1061-1711","1615-5939"],"issn-type":[{"type":"print","value":"1061-1711"},{"type":"electronic","value":"1615-5939"}],"subject":[],"published":{"date-parts":[[2019,9,20]]}}}